These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19851773)

  • 1. Infliximab therapy in pediatric Takayasu's arteritis: report of two cases.
    Buonuomo PS; Bracaglia C; Campana A; Insalaco A; Pardeo M; Cortis E; Ugazio AG
    Rheumatol Int; 2011 Jan; 31(1):93-5. PubMed ID: 19851773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature.
    Comarmond C; Plaisier E; Dahan K; Mirault T; Emmerich J; Amoura Z; Cacoub P; Saadoun D
    Autoimmun Rev; 2012 Jul; 11(9):678-84. PubMed ID: 22155781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Takayasu's arteritis progression on anti-TNF biologics: a case series.
    Osman M; Aaron S; Noga M; Yacyshyn E
    Clin Rheumatol; 2011 May; 30(5):703-6. PubMed ID: 21221688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature.
    Novikov PI; Smitienko IO; Moiseev SV
    Clin Rheumatol; 2013 Dec; 32(12):1827-32. PubMed ID: 23995735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refractory Takayasu arteritis successfully treated with infliximab.
    Maffei S; Di Renzo M; Santoro S; Puccetti L; Pasqui AL
    Eur Rev Med Pharmacol Sci; 2009; 13(1):63-5. PubMed ID: 19364087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infliximab therapy for three adolescent patients with refractory Takayasu's arteritis].
    Kaneko U; Kishi T; Kikuchi M; Hara R; Shinoki T; Miyamae T; Imagawa T; Mori M; Yokota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(6):317-23. PubMed ID: 21212584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Takayasu's arteritis with tumor necrosis factor antagonists.
    Filocamo G; Buoncompagni A; Viola S; Loy A; Malattia C; Ravelli A; Martini A
    J Pediatr; 2008 Sep; 153(3):432-4. PubMed ID: 18718263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab-responsive uveitis and vasculitis in a patient with Takayasu arteritis.
    Jolly M; Curran JJ
    J Clin Rheumatol; 2005 Aug; 11(4):213-5. PubMed ID: 16357759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab.
    Quartuccio L; Schiavon F; Zuliani F; Carraro V; Catarsi E; Tavoni AG; Bombardieri S; Punzi L; De Vita S
    Clin Exp Rheumatol; 2012; 30(6):922-8. PubMed ID: 23044074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.
    Schmidt J; Kermani TA; Bacani AK; Crowson CS; Matteson EL; Warrington KJ
    Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1079-83. PubMed ID: 22328491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cases of Takayasu's arteritis occurring under anti-TNF therapy.
    Mariani N; So A; Aubry-Rozier B
    Joint Bone Spine; 2013 Mar; 80(2):211-3. PubMed ID: 22999907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab in Takayasu arteritis: a safe alternative?
    Karageorgaki ZT; Mavragani CP; Papathanasiou MA; Skopouli FN
    Clin Rheumatol; 2007 Jun; 26(6):984-7. PubMed ID: 16633710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.
    Hoffman GS; Merkel PA; Brasington RD; Lenschow DJ; Liang P
    Arthritis Rheum; 2004 Jul; 50(7):2296-304. PubMed ID: 15248230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Takayasu's arteritis in a patient with Crohn's disease: an unexpected association during infliximab therapy.
    Katoh N; Kubota M; Shimojima Y; Ishii W; Matsuda M; Akamatsu T; Ikeda S
    Intern Med; 2010; 49(2):179-82. PubMed ID: 20075586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory Takayasu's arteritis successfully treated with the human, monoclonal anti-tumor necrosis factor antibody adalimumab.
    Tatò F; Rieger J; Hoffmann U
    Int Angiol; 2005 Sep; 24(3):304-7. PubMed ID: 16158044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Takayasu's aortitis and infliximab.
    El-Matary W; Persad R
    J Pediatr; 2009 Jul; 155(1):151. PubMed ID: 19559311
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful golimumab therapy in four patients with refractory Takayasu's arteritis.
    Suematsu R; Tashiro S; Ono N; Koarada S; Ohta A; Tada Y
    Mod Rheumatol; 2018 Jul; 28(4):712-715. PubMed ID: 26707139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.
    Calderón R; Estrada S; Ramírez de la Piscina P; Salvador M; Zabaleta S; Enciso C; Delgado E; García-Campos F
    Rev Esp Enferm Dig; 2010 Feb; 102(2):145-6. PubMed ID: 20361852
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biologic therapies in the systemic vasculitides].
    Díaz-Orta MA; Rojas-Serrano J
    Reumatol Clin; 2011 Dec; 7 Suppl 3():S33-6. PubMed ID: 22152288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-TNF alpha agents in vasculitis].
    Solans Laqué R; Bosch Gil JA
    Med Clin (Barc); 2008 Feb; 130(3):93-4. PubMed ID: 18261379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.